Ticker Details
Spruce Biosciences, Inc.
IPO Date:	October 9, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$142.4M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.92 | 6.06%
Avg Daily Range (30 D):	$1.56 | 3.07%
Avg Daily Range (90 D):	$2.37 | 4.06%

Institutional Daily Volume
Avg Daily Volume:	.06M
Avg Daily Volume (30 D):	.05M
Avg Daily Volume (90 D):	.05M

Trade Size
Avg Trade Size (Sh.):	25
Avg Trade Size (Sh.) (30 D):	37
Avg Trade Size (Sh.) (90 D):	39

Institutional Trades
Total Institutional Trades:	81
Avg Institutional Trade:	$2.07M
Avg Institutional Trade (30 D):	$2.99M
Avg Institutional Trade (90 D):	$2.84M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.08M
Avg Closing Trade (30 D):	$5.06M
Avg Closing Trade (90 D):	$4.36M
Avg Closing Volume:	41.64K

News

Apr 21, 2026 @ 9:15 AM Stock Market Today: Dow Jones, S&P 500 Futures Edg... Source: Benzinga Staff Writer

Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight

May 13, 2024 @ 9:10 PM Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, T... Source: Zacks Equity Research

May 1, 2024 @ 11:55 AM Pfizer (PFE) Q1 Earnings and Revenues Beat Estimat... Source: Zacks Equity Research

Mar 27, 2024 @ 4:00 PM Spruce Biosciences (SPRB) Upgraded to Buy: Here's ... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-36.6	$-8.94	$-9.58
Diluted EPS	$-36.6	$-8.94	$-9.58
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-37.19M	$-12.27M	$-14.65M
Operating Income / Loss	$-34.01M	$-11.99M	$-11.1M
Cost of Revenue
Net Cash Flow	$22.61M	$22.61M	$M
PE Ratio

Splits
Aug 07, 2025	1:75